(E)-N-(3-(4,5-dimethoxy-2-nitrophenyl)-3-oxoprop-1-en-1-yl)-N-methylnitrous amide
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

(E)-N-(3-(4,5-dimethoxy-2-nitrophenyl)-3-oxoprop-1-en-1-yl)-N-methylnitrous amide

● In Stock

Catalogue No.:VE0022770
CAS No.:N/A
Mol. Formula:C12H13N3O6
Mol. Weight:295.25 g/mol

Additional information on (E)-N-(3-(4 | 5-dimethoxy-2-nitrophenyl)-3-oxoprop-1-en-1-yl)-N-methylnitrous amide

Parent drug

Cabozantinib

IUPAC Name

(E)-N-(3-(4, 5-dimethoxy-2-nitrophenyl)-3-oxoprop-1-en-1-yl)-N-methylnitrous amide

Pharmacopoeial Synonyms

N/A

Other Synonyms

N/A

Smiles

COC1=C(OC)C=C(C(/C=C/N(N=O)C)=O)C([N+]([O-])=O)=C1

InChI

InChI=1S/C12H13N3O6/c1-14(13-17)5-4-10(16)8-6-11(20-2)12(21-3)7-9(8)15(18)19/h4-7H, 1-3H3/b5-4+

Description

The compound (E)-N-(3-(4 | 5-dimethoxy-2-nitrophenyl)-3-oxoprop-1-en-1-yl)-N-methylnitrous amide is a thoroughly characterized reference standard that complies with rigorous regulatory guidelines | including those from USP | EMA | JP | and BP. It is ideal for critical applications such as analytical method development | method validation (AMV) | and quality control (QC) | especially in the production of Cabozantinib. Designed to support both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA) | this product delivers the precision required for reliable results. Additionally | it includes a detailed Structure Elucidation Report (SER) | ensuring accuracy and dependability for advanced analytical purposes.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url